Ascidian Therapeutics
Healthcare & Life Sciences
Recent Finacing
Series A
Recent Raise
$40M
Ascidian Therapeutics is a biotechnology company focused on developing RNA exon editing therapies to treat Stargardt disease and other ABCA4 retinopathies, as well as central nervous system and neuromuscular diseases.
Focus Areas
Biotechnology
RNA Exon Editing
Stargardt Disease Treatment
ABCA4 Retinopathies
Central Nervous System Diseases
Neuromuscular Diseases
Investors
